Patent details

91065 Product Name: Drospirenone en combinaison avec oestradiol et leurs dérivés pharmaceutiquement acceptables (Allurene-Angeliq)

Basic Information

Publication number:
91065
Type:
SPC
SPC Type:
Medical
Basic Patent Number:
EP902501279
Legal Status:
Expired
Application number:
91065
First applicant's nationality:
Procedural language:
French

Marketing Authorization

1

Marketing Authorization Number:
0581/03/0024-0354817,0581/03/10/0024-035482
Marketing Authorization Type:
Marketing Authorization Date:
30/09/2003
Marketing Authorization Status:
Accepted
Marketing Authorization Country:
Luxembourg (LU)

2

Marketing Authorization Number:
RVG 27505
Marketing Authorization Type:
Marketing Authorization Date:
11/12/2002
Marketing Authorization Status:
Accepted
Marketing Authorization Country:
Netherlands (NL)

Dates

Filing date:
30/03/2004
First Marketing Authorization date:
11/12/2002
Grant date:
01/06/2004
Activation date:
16/05/2010
Publication date:
01/06/2004
Lapsed date:
Expiration date:
Renunciation date:
Revocation date:
Annulment date:
Basic SPC Expiration:
16/05/2015
SPC Extension Expiration:
16/05/2015
Rejection date:
Withdrawal date:

Owner

From:
25/11/2009
 
 

Name:
BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
Address:
MÜLLERSTRASSE 178, 13353, BERLIN, Germany (DE)

History of Owners

From:
30/03/2004
To:
24/11/2009

Name:
SCHERING AKTIENGESELLSCHAFT
Address:
-, 13342, BERLIN, Germany (DE)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
30/03/2004
Address:
PO Box 48, 8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
Elger Walter, Dr.
Address:
Germany (DE)

2

Name:
Beier Sybille, Dr.
Address:
Germany (DE)

3

Name:
Wiechert Rudolf, Prof.-Dr.-Dr.
Address:
Germany (DE)

4

Name:
Nishino Yukishige, Dr.
Address:
Germany (DE)
Filing date Document type Number of pages